Date and time: Tue 03-Nov-2020, 14:00-14:20
Programme theme(s): Immunology and immunotherapy
Programme session type(s): Lightning talks
Cancer sites: Bladder and renal, Breast, Lung
Interest for: Clinicians, Scientists, Trainees
This session is supported by an unrestricted educational grant from Promega UK.
They had no involvement in topic or speaker selection.
They had no involvement in topic or speaker selection.
Abstract title: Retrospective review of the efficacy and tolerability of neoadjuvant biosimilar Trastuzumab (Herzuma) in combination with Pertuzumab and chemotherapy in HER2-positive early breast cancer.
Abstract title: Atezolizumab and Pembrolizumab Immunotherapy in the treatment of metastatic urothelial cancers – real world experience in Devon and Cornwall.
Abstract title: Clinical correlates of peripheral T cell immune awakening
Abstract title: Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated with First-line Palliative Chemoimmunotherapy